Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Looking only at national prevalence masks hot spots where resources to combat the epidemic are most needed.
Researchers found that drawing out the delivery of the vaccine over a number of days yielded a stronger immune response.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
If Black women had white women’s lower HIV rate, 93% of their annual new infections would be averted.
Researchers surveyed PrEP-prescribing physicians in Western New York.
Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.
Leronlimab (PRO 140) also shows promise as a treatment for cancer and graft-versus-host disease.
Researchers in an ongoing study are analyzing condom use among men who have sex with men in Chicago.
Researchers broke down the various strategies that the gay men in the Opposites Attract study used to prevent HIV transmission.
However, because this combo is not as effective as the current standard treatment, the search for new options continues.
A pillar of the city’s “Getting to Zero” plan to combat HIV is getting to “zero HIV stigma” by 2030.
Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.
Two gene-editing experts said Jiankui He’s actions were a “gross violation” of Chinese regulations and international standards.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.